Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 365

1.

Prevalence of Anal High-Risk Human Papillomavirus Infections Among HIV-Positive and HIV-Negative Men Who Have Sex With Men in Nigeria.

Nowak RG, Gravitt PE, He X, Ketende S, Dauda W, Omuh H, Blattner WA, Charurat ME; TRUST Study Group.

Sex Transm Dis. 2016 Apr;43(4):243-8. doi: 10.1097/OLQ.0000000000000431.

PMID:
26967301
2.

Serosorting and Sexual Risk for HIV Infection at the Ego-Alter Dyadic Level: An Egocentric Sexual Network Study Among MSM in Nigeria.

Rodriguez-Hart C, Liu H, Nowak RG, Orazulike I, Zorowitz S, Crowell TA, Baral SD, Blattner W, Charurat M.

AIDS Behav. 2016 Feb 24. [Epub ahead of print]

PMID:
26910338
3.

Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria.

Royal W 3rd, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC, Blattner WA.

PLoS One. 2016 Feb 1;11(2):e0147182. doi: 10.1371/journal.pone.0147182. eCollection 2016.

4.

Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.

Dolcetti R, Giagulli C, He W, Selleri M, Caccuri F, Eyzaguirre LM, Mazzuca P, Corbellini S, Campilongo F, Marsico S, Giombini E, Muraro E, Rozera G, De Paoli P, Carbone A, Capobianchi MR, Ippolito G, Fiorentini S, Blattner WA, Lu W, Gallo RC, Caruso A.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14331-6. doi: 10.1073/pnas.1514748112. Epub 2015 Nov 2. Erratum in: Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):E7033.

5.

Developing National Cancer Registration in Developing Countries - Case Study of the Nigerian National System of Cancer Registries.

Jedy-Agba EE, Oga EA, Odutola M, Abdullahi YM, Popoola A, Achara P, Afolayan E, Banjo AA, Ekanem IO, Erinomo O, Ezeome E, Igbinoba F, Obiorah C, Ogunbiyi O, Omonisi A, Osime C, Ukah C, Osinubi P, Hassan R, Blattner W, Dakum P, Adebamowo CA.

Front Public Health. 2015 Jul 30;3:186. doi: 10.3389/fpubh.2015.00186. eCollection 2015. Review.

6.

The immediate eff ect of the Same-Sex Marriage Prohibition Act on stigma, discrimination, and engagement on HIV prevention and treatment services in men who have sex with men in Nigeria: analysis of prospective data from the TRUST cohort.

Schwartz SR, Nowak RG, Orazulike I, Keshinro B, Ake J, Kennedy S, Njoku O, Blattner WA, Charurat ME, Baral SD; TRUST Study Group.

Lancet HIV. 2015 Jul;2(7):e299-306.

PMID:
26125047
7.

Analysis of reverse transcriptase and protease genes of HIV for antiretroviral drug resistance in treatment-exposed Jamaican pediatrics.

Ramkissoon AP, Amarakoon II, Hamilton CL, Pierre RB, Eyzaguirre LM, Carr JK, Blattner WA, Roye ME.

AIDS Res Hum Retroviruses. 2015 Sep;31(9):932-7. doi: 10.1089/AID.2015.0122. Epub 2015 Aug 5.

PMID:
26122980
8.

HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population.

Riedel DJ, Rositch AF, Redfield RR, Blattner WA.

Leuk Lymphoma. 2015 Jun 19:1-7. [Epub ahead of print]

PMID:
26025299
9.

Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.

Coker M, Etiebet MA, Chang H, Awwal G, Jumare J, Musa BM, Babashani M, Habib AG, Dakum P, Abimiku AG, Charurat ME, Blattner WA, Eng M, Ndembi N.

Curr HIV Res. 2015;13(4):279-85.

PMID:
25845393
10.

Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria.

Nwofor AC, Nyamngee A, Nwabuisi C, Iwakun M, Gidado M, Mensah C, Dakum P, Agbede OO, Ndembi N, Blattner WA, Abimiku AG.

Curr HIV Res. 2015;13(4):308-14.

PMID:
25845392
11.

HIV-1 Antiretroviral Drug Resistance in Pregnant Women in Jamaica: A Preliminary Report.

Amarakoon II, Ramkissoon A, Pierre R, Eyzaguirre LM, Carr JK, Blattner WA, Roye ME.

West Indian Med J. 2014 Jul 3;63(6):596-600. doi: 10.7727/wimj.2014.016. Epub 2014 Aug 21.

12.

Correlates of Patient Retention in HIV Care and Treatment Programs in Nigeria.

Ugoji C, Okere N, Dakum P, Ake-Uzoigwe R, Igboelina D, Ndembi N, Ekong E, Charurat M, Blattner WA.

Curr HIV Res. 2015;13(4):300-7.

PMID:
25777516
13.

Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.

Charurat ME, Emmanuel B, Akolo C, Keshinro B, Nowak RG, Kennedy S, Orazulike I, Ake J, Njoku O, Baral S, Blattner W; TRUST Study Group.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S114-23. doi: 10.1097/QAI.0000000000000439.

PMID:
25723975
14.

Evaluating respondent-driven sampling as an implementation tool for universal coverage of antiretroviral studies among men who have sex with men living with HIV.

Baral SD, Ketende S, Schwartz S, Orazulike I, Ugoh K, Peel SA, Ake J, Blattner W, Charurat M.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S107-13. doi: 10.1097/QAI.0000000000000438.

15.

Adherence to Anti-Retroviral Therapy in North Central Nigeria.

Avong YK, van Wyk B, Njab J, Abimiku AG, Ndembi N, Okuma J, Ogbanufe O, Ekong E, Dakum P, Blattner WA.

Curr HIV Res. 2015;13(4):268-78.

PMID:
25642849
16.

Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Hungerford L, Obasanya J, Blattner W.

BMC Infect Dis. 2014 Dec 13;14:675. doi: 10.1186/s12879-014-0675-0.

17.

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants.

Frey SE, Peiperl L, McElrath MJ, Kalams S, Goepfert PA, Keefer MC, Baden LR, Lally MA, Mayer K, Blattner WA, Harro CD, Hammer SM, Gorse GJ, Hural J, Tomaras GD, Levy Y, Gilbert P, deCamp A, Russell ND, Elizaga M, Allen M, Corey L.

Clin Vaccine Immunol. 2014 Nov;21(11):1589-99. doi: 10.1128/CVI.00450-14. Epub 2014 Sep 24.

18.

Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications.

Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ; AIDS Seroepidemiology Collaborative Working Group, Gallo RC, Blattner WA.

JAMA. 2014 Jul 23-30;312(4):442. doi: 10.1001/jama.2013.279636. No abstract available.

PMID:
25038372
19.

Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.

Akolo C, Royal W 3rd, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, Umlauf A, Hendrix T, Johnson J, Abimiku A, Blattner WA.

J Neurovirol. 2014 Aug;20(4):380-7. doi: 10.1007/s13365-014-0254-6. Epub 2014 Jun 14.

20.

Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort.

Luo W, Masciotra S, Delaney KP, Charurat M, Croxton T, Constantine N, Blattner W, Wesolowski L, Owen SM.

J Clin Virol. 2013 Dec;58 Suppl 1:e113-8. doi: 10.1016/j.jcv.2013.08.017.

PMID:
24342470
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk